Skip to search formSkip to main contentSkip to account menu

Combivent Respimat

Known as: Respimat, Combivent 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background Patients with chronic obstructive pulmonary disease (COPD) show signs of reduced physical activity from the early… 
2018
2018
Abstract The effectiveness of the tiotropium Respimat® formulation in routine clinical practice is still an open issue due to… 
2015
2015
Anlässlich der europäischen Zulassung von Tiotropium/Olodaterol (Spiolto®) legte Prof. Dr. Klaus Rabe, Kiel, dar, dass die… 
Highly Cited
2005
Highly Cited
2005
IntroductionIn addition to offering favorable pharmaceutical performance, an ideal inhaler should be well accepted by patients… 
2004
2004
ObjectiveRespimat® Soft Mist™ Inhaler (SMI) is a novel, propellant-free device that significantly increases lung deposition…